SEC Filing Summary: Blackstone Inc. (Form 13F)
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Blackstone Inc. for the reporting period ending December 31, 2024. The document discloses the equity securities held by the investment manager at the end of the quarter. It does not contain financial performance data (revenue, profit, cash flow) for Blackstone Inc. itself, but rather a snapshot of its investment portfolio holdings.
Key Financial Metrics and Portfolio Composition
The filing lists specific holdings by issuer, class, CUSIP, value, and share count. Key observations regarding the portfolio include:
- Asset Classes: The portfolio is heavily weighted toward Energy Midstream (e.g., Cheniere Energy Partners, Enterprise Products Partners, Williams Cos), Biotechnology (e.g., Amicus Therapeutics, Compass Therapeutics, Autolus Therapeutics), and Technology (e.g., Amazon, Block, DigitalOcean).
- Notable Holdings:
- Cheniere Energy Partners LP: 102,082,466 shares valued at approximately $5.42 billion.
- FirstEnergy Corp: 28,832,099 shares valued at approximately $1.15 billion.
- Blackstone Mortgage Trust Inc: 8,601,492 shares held with Sole voting authority.
- Corebridge Financial Inc: 61,962,123 shares held with Sole voting authority.
- Debt Instruments: The filing includes specific notes (debt securities) such as Block Inc. (0.125%), Confluent Inc., DigitalOcean Holdings, Okta Inc., RingCentral Inc., and Sunnova Energy Intl.
- Voting Authority: Most positions are listed under "Other" (OTR) voting authority, indicating shared or discretionary management, though specific positions in Blackstone-affiliated entities and Corebridge Financial are marked as "Sole."
Material Changes Versus Prior Period
The filing text does not provide a clear value for material changes compared to the prior comparable period. Form 13F tables typically list only the current quarter's holdings and do not explicitly state the net change (buy/sell) from the previous quarter within the data rows provided.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for management commentary, guidance, outlook, or specific risk factors. This document is a statutory disclosure of holdings and does not contain narrative sections regarding future strategy or contingencies. The standard SEC disclaimer notes that the Commission has not reviewed the information for accuracy.
Important Facts for Investor Verification
- Portfolio Concentration: Verify the concentration risk in the Energy Midstream sector, which represents a significant portion of the disclosed value (e.g., Cheniere, Enterprise, Williams, Targa).
- Biotech Exposure: Note the substantial holdings in smaller-cap biotechnology firms (e.g., Autolus Therapeutics, Compass Therapeutics), which may carry higher volatility.
- Internal Holdings: Confirm the voting authority status of Blackstone-affiliated entities (Blackstone Mortgage Trust, Blackstone Secured Lending Fund) which are held with "Sole" authority.
- Debt vs. Equity: Distinguish between equity positions and the specific corporate notes held (e.g., Sunnova Energy notes totaling over $48 million in principal).
- Data Limitations: Acknowledge that this filing does not reflect the total assets under management (AUM) of Blackstone Inc., but only the specific equity securities required to be reported under Section 13(f) of the Exchange Act.